A strategic partnership has been announced between biopharmaceutical contract services company, KBI, and provider of formulation development collaborations and product-specific licenses for a broad spectrum of protein-based therapeutics, ReForm
Original Article: Strategic partnership formed to develop and validate biologic formulation platform